362 related articles for article (PubMed ID: 14871854)
1. Ex vivo expansion of CD8+CD56+ and CD8+CD56- natural killer T cells specific for MUC1 mucin.
Wajchman HJ; Pierce CW; Varma VA; Issa MM; Petros J; Dombrowski KE
Cancer Res; 2004 Feb; 64(3):1171-80. PubMed ID: 14871854
[TBL] [Abstract][Full Text] [Related]
2. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.
Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG
J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298
[TBL] [Abstract][Full Text] [Related]
3. beta-cell antigen-specific CD56(+) NKT cells from type 1 diabetic patients: autoaggressive effector T cells damage human CD56(+) beta cells by HLA-restricted and non-HLA-restricted pathways.
Ou D; Metzger DL; Wang X; Pozzilli P; Tingle AJ
Hum Immunol; 2002 Apr; 63(4):256-70. PubMed ID: 12039407
[TBL] [Abstract][Full Text] [Related]
4. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets.
Stremmel C; Exley M; Balk S; Hohenberger W; Kuchroo VK
Eur J Immunol; 2001 Sep; 31(9):2818-28. PubMed ID: 11536181
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo expansion of CD56+ NK and NKT-like lymphocytes from peripheral blood mononuclear cells of patients with ovarian neoplasia.
Alves PCM; De Angelo Andrade LAL; Petta CA; Lorand-Metze I; Derchain SF; Guimarães F
Scand J Immunol; 2011 Sep; 74(3):244-252. PubMed ID: 21595734
[TBL] [Abstract][Full Text] [Related]
7. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
8. Functional and Vbeta repertoire characterization of human CD8+ T-cell subsets with natural killer cell markers, CD56+ CD57- T cells, CD56+ CD57+ T cells and CD56- CD57+ T cells.
Takayama E; Koike Y; Ohkawa T; Majima T; Fukasawa M; Shinomiya N; Yamaguchi T; Konishi M; Hiraide H; Tadakuma T; Seki S
Immunology; 2003 Feb; 108(2):211-9. PubMed ID: 12562330
[TBL] [Abstract][Full Text] [Related]
9. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition.
Pietra G; Romagnani C; Falco M; Vitale M; Castriconi R; Pende D; Millo E; Anfossi S; Biassoni R; Moretta L; Mingari MC
Eur J Immunol; 2001 Dec; 31(12):3687-93. PubMed ID: 11745389
[TBL] [Abstract][Full Text] [Related]
10. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
[TBL] [Abstract][Full Text] [Related]
11. NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease.
Azeredo EL; De Oliveira-Pinto LM; Zagne SM; Cerqueira DI; Nogueira RM; Kubelka CF
Clin Exp Immunol; 2006 Feb; 143(2):345-56. PubMed ID: 16412060
[TBL] [Abstract][Full Text] [Related]
12. HER-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3(+)CD56(+) (natural killer T) lymphocytes.
Baxevanis CN; Gritzapis AD; Tsitsilonis OE; Katsoulas HL; Papamichail M
Int J Cancer; 2002 Apr; 98(6):864-72. PubMed ID: 11948464
[TBL] [Abstract][Full Text] [Related]
13. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R
AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel subset of CD8(+) T cells that expands in patients receiving interleukin-12.
Gollob JA; Schnipper CP; Orsini E; Murphy E; Daley JF; Lazo SB; Frank DA; Neuberg D; Ritz J
J Clin Invest; 1998 Aug; 102(3):561-75. PubMed ID: 9691093
[TBL] [Abstract][Full Text] [Related]
15. The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody.
Jin Y; Fuller L; Carreno M; Esquenazi V; Tzakis AG; Miller J
Hum Immunol; 1998 Jun; 59(6):352-62. PubMed ID: 9634197
[TBL] [Abstract][Full Text] [Related]
16. Contribution of Leishmania braziliensis antigen-specific CD4+ T, CD8+ T, NK and CD3+CD56+NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles.
Cunha CF; Ferraz-Nogueira R; Costa VFA; Pimentel MIF; Chometon TQ; Lyra MR; Schubach AO; Da-Cruz AM; Bertho AL
PLoS One; 2020; 15(3):e0229400. PubMed ID: 32203546
[TBL] [Abstract][Full Text] [Related]
17. IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells.
Watkinson F; Nayar SK; Rani A; Sakellariou CA; Elhage O; Papaevangelou E; Dasgupta P; Galustian C
Front Immunol; 2020; 11():594620. PubMed ID: 33537030
[TBL] [Abstract][Full Text] [Related]
18. Identification of a distinct NK-like hepatic T-cell population activated by NKG2C in a TCR-independent manner.
Koh JY; Rha MS; Choi SJ; Lee HS; Han JW; Nam H; Kim DU; Lee JG; Kim MS; Park JY; Park SH; Joo DJ; Shin EC
J Hepatol; 2022 Oct; 77(4):1059-1070. PubMed ID: 35644434
[TBL] [Abstract][Full Text] [Related]
19. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.
Falk CS; Steinle A; Schendel DJ
J Exp Med; 1995 Oct; 182(4):1005-18. PubMed ID: 7561674
[TBL] [Abstract][Full Text] [Related]
20. Alpha-glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3-CD56+ NK cells in vitro.
Ishihara S; Nieda M; Kitayama J; Osada T; Yabe T; Kikuchi A; Koezuka Y; Porcelli SA; Tadokoro K; Nagawa H; Juji T
J Immunol; 2000 Aug; 165(3):1659-64. PubMed ID: 10903777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
